Enzon Pharmaceuticals Inc (ENZN.O)

ENZN.O on Consolidated Issue listed on NASDAQ Capital Market

1.00USD
29 Jan 2015
Change (% chg)

-- (--)
Prev Close
$1.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
208,373
52-wk High
$1.66
52-wk Low
$0.71

ENZN.O

Chart for ENZN.O

About

Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company’s drug development programs utilize two platforms: Customized PEGylation Linker Technology (Customized Linker Technology) and third-generation messenger ribonucleic acid (mRNA) antagonists utilizing the Locked Nucleic Acid (LNA) technology. The Company... (more)
No analyst recommendations are available for ENZN.O.

Overall

Beta: 1.30
Market Cap(Mil.): $44.01
Shares Outstanding(Mil.): 44.14
Dividend: 0.10
Yield (%): --

Financials

  ENZN.O Industry Sector
P/E (TTM): 1.56 206.52 40.74
EPS (TTM): 0.64 -- --
ROI: 116.18 -0.84 18.19
ROE: 118.64 -2.65 19.08
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks